DRD4 and Alzheimer disease: Interesting, D(4) dopamine receptors, which are targets of anti-Parkinson medications, such as levodopa, ropinirole, and pramipexole, have an RC > 1, indicating an increased risk of AD + P. A more detailed discussion can be found in the Supplementary Materials.